What is ArriVent BioPharma, Inc.'s debt-to-equity?

ArriVent BioPharma, Inc. (AVBP) reported debt-to-equity of 0× in Q1 2026.

How has ArriVent BioPharma, Inc.'s debt-to-equity changed year-over-year?

ArriVent BioPharma, Inc.'s debt-to-equity increased by 85.7% year-over-year, from 0× to 0×.

What does debt-to-equity mean?

Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.

ArriVent BioPharma, Inc. AVBP Debt-to-equity

Debt-to-equity at other companies

Johnson & JohnsonJNJ

0.7×0.0×

Syndax PharmaceuticalsSNDX

8.4×+6.9×

Nuvation BioNUVB

0.2×+0.2×

ImmunomeIMNM

0×0.0×

Arcus BiosciencesRCUS

0.2×+0.1×

Erasca, Inc.ERAS

0.1×0.0×

Other financials

Income statement

See full

Operating income-$46.1M+30.9%

Net income-$43.3M+32.7%

EPS (diluted)-$0.96+49.5%

Balance sheet

See full

Cash & equivalents$62.1M+24.5%

Total debt$419.0K+204%

Total equity$324.0M+60.0%

Total assets$349.3M+62.1%

Cash flow

See full

Operating cash flow-$41.9M+38.4%

Valuation

See full

Market cap$1.57B+62.1%

Enterprise value$1.51B+65.4%

Returns & leverage

See full

Return on equity-55.2%+8.0pp

Current ratio14×-0.4×

Where this comes from

Calculated from ArriVent BioPharma, Inc.’s reported figures.

total debt/total stockholders equity=0×

Based on the most recent quarter.

The official record: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about ArriVent BioPharma, Inc.'s debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ArriVent BioPharma, Inc.'s debt-to-equity?: ArriVent BioPharma, Inc. (AVBP) reported debt-to-equity of 0× in Q1 2026.
How has ArriVent BioPharma, Inc.'s debt-to-equity changed year-over-year?: ArriVent BioPharma, Inc.'s debt-to-equity increased by 85.7% year-over-year, from 0× to 0×.
What does debt-to-equity mean?: Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.